Absence of Parathyroid Hormone Messenger RNA in Nonparathyroid Tumors Associated with Hypercalcemia

Ellen L. Simpson, Gregory R. Mundy, Sharyn M. D'souza, Kenneth J. Ibbotson, Richard Bockman, John W. Jacobs

Research output: Contribution to journalArticlepeer-review

98 Scopus citations


We used a sensitive and specific hybridization assay that detects evidence of parathyroid hormone synthesis in tumors to investigate whether this hormone mediates the hypercalcemia of malignant disease. The assay uses Radio-labeled, cloned parathyroid hormone DNA to hybridize selectively with parathyroid hormone messenger RNA. We assayed 13 human and 3 animal tumors of diverse cell origins that are frequently associated with the hypercalcemia of cancer. Five of the human tumors were obtained from patients known to be hypercalcemic at the time of tumor excision, two were from normocalcemic patients, and six were from patients with breast cancer whose serum calcium levels were unknown. Messenger RNA was prepared from cultured cell lines or tumors; active RNA fractions were hybridized with either human or bovine cloned parathyroid hormone DNA that had been labeled to a high specific activity with [32P]nucleotide. We were unable to detect parathyroid hormone RNA transcripts in any of the tumors. Our results indicate that parathyroid hormone rarely, if ever, causes hypercalcemia in malignant disease. (N Engl J Med 1983; 309: 325–30.) Hypercalcemia is frequently associated with malignant disease. Such hypercalcemia is due to an increase in bone resorption, but the pathogenesis of the increase is unknown in the majority of cases.1 In patients with myeloma and other hematologic neoplasms, the lymphokine osteoclast-activating factor is the likely causative mediator.2 However, hypercalcemia also occurs in patients who have solid tumors without osteolytic bone destruction. Since this type of hypercalcemia is often associated with hypophosphatemia and increased nephrogenous cyclic AMP generation,3 which are features of excessive parathyroid hormone, the condition has been called “ectopic hyperparathyroidism” or “pseudohyperparathyroidism.” The frequency of ectopic production of parathyroid.

Original languageEnglish (US)
Pages (from-to)325-330
Number of pages6
JournalNew England Journal of Medicine
Issue number6
StatePublished - Aug 11 1983

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Absence of Parathyroid Hormone Messenger RNA in Nonparathyroid Tumors Associated with Hypercalcemia'. Together they form a unique fingerprint.

Cite this